1. Каприн А.Д., Старинский В.В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность) - М.: МНИОИ им. П.А. Герцена филиал ФГБУ «НМИРЦ» Минздрава России, 2017., с.11, 15, 16
2. Давыдов М.И. Энциклопедия клинической онкологии Москва, ООО «РЛС-2004», 2004
3. Л.Х. Собин, М. Господарович, К. Виттекинд. TNM. Классификация злокачественных опухолей.- 7-е издание - М.: Логосфера, 2011, стр. 45-49.
4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cancer of the Oral Cavity. Cancer of the Supraglottic Larynx. Version 1.2016.
5. Haddadin KJ, Soutar DS, Oliver RJ, et al. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21(6):517-525
6. Teymoortash, A. Current advanced in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer / A. Teymoortash, J.A. Werner // GMS Curr. Top Otorhinolaryngol. Head Neck Surg. — 2012. — Vol. 11. — P. 04.
7. Жуманкулов А.М., Остринская Т.В., Литвинов А.П., Лебедева Ж.С. Брахитерапия злокачественных опухолей полости рта и ротоглотки. Опухоли головы и шеи. 2015;5(4):41-47.
8. American Joint Committee on Cancer. Pharynx. In: AJCC Cancer Staging Manual, 7th ed. New York, Springer: 2010; 41-49. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-
9. Atkinson JC, Harvey KE, Domingo DL, et al. Oral and dental phenotype of dyskeratosis congenita. Oral Dis. 2008;14:419-427.
10. Brown LM, McCarron P, Freedman DM. New Malignancies Following Cancer of the Buccal Cavity and Pharynx. In: Curtis RE,
11. Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr. (eds). New Malignancies Among Cancer Survivors: SEER Cancer Registries, 19732000. National Cancer Institute. NIH Publ. No. 05-5302. Bethesda, MD, 2006.
12. Bsoui SA, Huber MA, Terezhalmy GT. Squamous cell carcinoma of the oral tissues: A comprehensive review for oral healthcare providers. J Contemp Dent Pract. 2005;4:1-16.
13. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011 Nov 10;29(32):4294-4301. Epub 2011 Oct 3.
14. Cogliano V, Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol. 2004;5:708.
15. D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956.
16. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703. Epub 2012 Jan 26.
17. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control. 2005;16:347-358.
18. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772-1783.
19. . Koch WM, Stafford E, Bajaj G. Cancer of the Oral Cavity. Part A: General Principles and Management. In: Harrison LB, Sessions RB, Hong WK, eds. Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia, Pa: Lippincott Williams and Wilkins; 2009: 250-265.
20. Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003;129:106-112.
21. Menedenhall WM, Werning JW, Pfister DG. Treatment of head and neck cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:729-780.